Feature Channels: Immunology

• share
• favorite_border

In line with their commitment to strengthening communities through support that prioritizes equity, accessibility and inclusivity, Josh and Marjorie Harris through Harris Philanthropies, their family foundation, have made a six-figure donation to the Dolphins Challenge Cancer (DCC), the fundraising initiative of the Miami Dolphins Foundation. Harris Philanthropies’ generous support will be directed to Sylvester Comprehensive CancerCenter’s Game Changer community outreach vehicles, which bring cancer screenings and health information directly into underserved communities throughout South Florida.

• share
• favorite_border

Pregnant women continue to have reservations about getting vaccinated against COVID-19 despite research indicating the safety of the vaccines and the protection they may offer their unborn children.

• share
• favorite_border

Researchers at Moffitt Cancer Center want to improve their understanding of the immune environment in ovarian cancer in hopes of making immunotherapy an option for these patients. In a new study published in Cancer Cell, they report on key characteristics of immune cells in ovarian cancer and identify cell types important for mediating an immune response.

• share
• favorite_border

The antibodies generated by Pfizer’s COVID-19 vaccine rise more slowly and decline more quickly than those generated by the Moderna vaccine, according to a new study from UVA Health.

• share
• favorite_border

Using retrospective clinical data and in-depth lab studies, researchers have discovered that vitamin E can enhance immunotherapy responses by stimulating dendritic cells in the tumor.

• share
• favorite_border

UC San Diego study shows chronic JUUL use leads to inflammatory changes across the body, and may affect organs’ response to infection; results depend on e-cigarette flavor.

• share
• favorite_border

CoVac-1, a new vaccine against SARS-CoV-2, induced T-cell immune responses in 93 percent of patients with B-cell deficiencies, including many patients with leukemia and lymphoma, according to results presented at the AACR Annual Meeting 2022, held April 8-13.

• share
• favorite_border

Researchers at La Jolla Institute for Immunology (LJI) have found that Zika virus can mutate to become more infective—and potentially break through pre-existing immunity.

• share
• favorite_border

University of Maryland School of Medicine’s Institute of Human Virology contributes to Global Virus Network studies suggesting that the oral polio vaccine can protect people in developing nations that do not yet have access to COVID vaccines

• share
• favorite_border

Researchers at UC San Diego School of Medicine and Moores Cancer Center at UC San Diego Health, with collaborators, have further elucidated how ovarian cancer tumors defy immunotherapy, identifying new molecular targets that might boost immune response.

• share
• favorite_border

Moffitt Cancer Center researchers have revealed that the creation of an immunosuppressive environment is key to the progression of benign colorectal adenomas to invasive, malignant carcinomas. Their findings were published in Nature Communications.

• share
• favorite_border

A vaccine for hepatitis C has eluded scientists for more than 30 years, for several reasons.

• share
• favorite_border

SEATTLE — April 6, 2022 — Below are summaries of recent Fred Hutchinson Cancer Research Center research findings and other news. If you’re covering the American Association of Cancer Research’s annual meeting, April 8-13, see our list of Fred Hutch highlights for AACR and contact [email protected] for help setting up interviews with experts.

• share
• favorite_border

The gel, tested in mice, releases drugs and special antibodies that simultaneously deplete immune-blocking cells called macrophages from the surgical site and activate T cells so they can attack cancer.

• share
• favorite_border

Here are some of the latest articles that have been added to the Clinical Trials channel on Newswise.

• share
• favorite_border

Cardamonin — a natural compound found in the spice cardamom and other plants — could have therapeutic potential for triple-negative breast cancer, according to a new study using human cancer cells. The findings also show that the compound targets a gene that helps cancer cells elude the immune system.

• share
• favorite_border

Findings from a new study performed in mice suggest that omega-3 fatty acids could help immunotherapy and other treatments do a better job at fighting cancer. Immunotherapies, which stimulate the body’s own immune system to attack cancer, have revolutionized cancer treatment, but they don’t work for every patient.